AudioAbstracts
AudioAbstracts by ReachMD provides an easy-to-digest distillation of important medical literature in combination with digital linkage to in-depth information supporting the audio synopsis. AudioAbstracts harnesses the ReachMD digital network to broadcast the spoken synopsis and related digital links through its on-air, online, onsite, and mobile distribution network. Combining quick-read audio synopses with links to source material, AudioAbstracts is the smarter, faster way to stay current on medical literature.
16-30 of 54
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Living RheumAdverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Improved Pathogen ID in Sepsis with Clinical Metagenomic Sequencing
Clinician's RoundtableImproved Pathogen ID in Sepsis with Clinical Metagenomic Sequencing
Saliva as a Window Into Cystic Fibrosis: Metabolic Biomarkers and Clinical Potential
Clinician's RoundtableSaliva as a Window Into Cystic Fibrosis: Metabolic Biomarkers and Clinical Potential
OCT Biomarkers as Predictors of Treatment Response in RVO-Related Macular Edema
Eye on Ocular HealthOCT Biomarkers as Predictors of Treatment Response in RVO-Related Macular Edema
Triglycerides and Residual Risk in Secondary Cardiovascular Prevention: Lessons From UCC-SMART
Heart MattersTriglycerides and Residual Risk in Secondary Cardiovascular Prevention: Lessons From UCC-SMART
Decoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers
NeuroFrontiersDecoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers
- advertisement
Predicting Hydroxyurea Resistance in Polycythemia Vera with Machine Learning
Project Oncology®Predicting Hydroxyurea Resistance in Polycythemia Vera with Machine Learning
Beyond Disease Control: PROs With Odronextamab in R/R Follicular Lymphoma
Project Oncology®Beyond Disease Control: PROs With Odronextamab in R/R Follicular Lymphoma
Diagnosing Long COVID: Rheumatologic Implications of 2024 Criteria
Living RheumDiagnosing Long COVID: Rheumatologic Implications of 2024 Criteria
Axatilimab for Chronic Graft-Versus-Host Disease: A Look at a Phase 3 Trial
Project Oncology®Axatilimab for Chronic Graft-Versus-Host Disease: A Look at a Phase 3 Trial
Epithelial Cell Activation in Sjögren’s: A New Target in Chronic Inflammation
Living RheumEpithelial Cell Activation in Sjögren’s: A New Target in Chronic Inflammation
Are Subcutaneous Immunotherapies Expanding Access and Efficiency in Cancer Care?
Project Oncology®Are Subcutaneous Immunotherapies Expanding Access and Efficiency in Cancer Care?
- advertisement
Assessing Adverse Pregnancy Outcomes in Isolated Sjögren’s Disease
Living RheumAssessing Adverse Pregnancy Outcomes in Isolated Sjögren’s Disease
DESTINY-Breast04 Findings: T-DXd and Quality of Life in HER2-Low Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerDESTINY-Breast04 Findings: T-DXd and Quality of Life in HER2-Low Metastatic Breast Cancer
Advances in Heart Failure Care: FINEARTS-HF Findings on Finerenone
AudioAbstractsAdvances in Heart Failure Care: FINEARTS-HF Findings on Finerenone
